Study Title

Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients With Muscle Invasive Bladder Cancer (EFFORT-MIBC): A Phase II Prospective Trial

Study Details

Description:

Evaluate the impact of 18F-FDG-PET-CT on the staging of patients with muscle invasive bladder cancer. Based on the results of 2 18F-FDG-PET-CT's patients are stratified in non-metastatic, oligometastatic and polymetastatic bladder cancer patients and the treatment is adapted accordingly to improve overall survival.

Contacts:

Valerie Fonteyne, MD; PhD (Principal Investigator)

valerie.fonteyne@uzgent.be

+3293323015

Flor Verghote, MD

valerie.fonteyne@uzgent.be

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468